New ALK inhibitor alectinib halts lung cancer growth more than a year longer than crizotinib, with fewer severe side effects

Immunotherapy for mesothelioma could be on the horizon

Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery

Olaparib slows growth of BRCA-related metastatic breast cancer

Low testosterone after testicular cancer could be linked to chronic health problems

Single radiation treatment can sufficiently relieve spinal cord compression symptoms

EADO conference highlights

Theory and application of electrochemotherapy

Role of histologic regression in melanoma

Circulating tumour cells in melanoma

PD1/ CTLA4 : Upfront or sequentially?

New imaging approaches for the diagnosis of melanoma and skin cancer